The aortic valve microenvironment and its role in calcific aortic valve disease

被引:83
|
作者
Yip, Cindy Ying Yin [2 ]
Simmons, Craig A. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada
[3] Univ Toronto, Fac Dent, Toronto, ON M5S 3G8, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Aortic sclerosis; Aortic stenosis; Mechanobiology; Calcification; Biomechanics; MATRIX-METALLOPROTEINASE EXPRESSION; INTERSTITIAL CELL CALCIFICATION; FACTOR-KAPPA-B; TRANSFORMING GROWTH-FACTOR-BETA-1; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES; RECEPTOR ACTIVATOR; EARLY LESION; MYOFIBROBLASTS; STENOSIS;
D O I
10.1016/j.carpath.2010.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In calcific aortic valve disease, fibrotic and calcific lesions form focally in the fibrosa layer of the valve leaflets. Layer-specific pathosusceptibility suggests that the fibrosa microenvironment is permissive to pathological development. The cellular microenvironment in the aortic valve is defined by a variety of biomechanical-, biochemical-, and extracellular-mediated factors, some of which are unique to the fibrosa. Growing evidence supports the role of these microenvironmental cues in the local regulation of side-specific valve cell phenotypes and focal pathological alterations, revealing new insights into the cellular and molecular processes that contribute to calcific aortic valve disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 50 条
  • [41] Potential drug targets for calcific aortic valve disease
    Hutcheson, Joshua D.
    Aikawa, Elena
    Merryman, W. David
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (04) : 218 - 231
  • [42] The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease
    Hanna, Lydia
    Armour, Chloe
    Xu, Xiao Yun
    Gibbs, Richard
    BIOMEDICINES, 2022, 10 (06)
  • [43] Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease
    Nancy Coté
    Ablajan Mahmut
    Yohan Bosse
    Christian Couture
    Sylvain Pagé
    Sylvain Trahan
    Marie-Chloé Boulanger
    Dominique Fournier
    Philippe Pibarot
    Patrick Mathieu
    Inflammation, 2013, 36 : 573 - 581
  • [44] Calcific aortic valve stenosis: hard disease in the heart
    Peeters, Frederique E. C. M.
    Meex, Steven J. R.
    Dweck, Marc R.
    Aikawa, Elena
    Crijns, Harry J. G. M.
    Schurgers, Leon J.
    Kietselaer, Bas L. J. H.
    EUROPEAN HEART JOURNAL, 2018, 39 (28) : 2618 - +
  • [45] Calcific aortic valve disease: mechanisms, prevention and treatment
    Louis-Hippolyte Minvielle Moncla
    Mewen Briend
    Yohan Bossé
    Patrick Mathieu
    Nature Reviews Cardiology, 2023, 20 : 546 - 559
  • [46] Models for calcific aortic valve disease in vivo and in vitro
    Zhu, Zijin
    Liu, Zhirong
    Zhang, Donghui
    Li, Li
    Pei, Jianqiu
    Cai, Lin
    CELL REGENERATION, 2024, 13 (01)
  • [47] Adaptive immune cells in calcific aortic valve disease
    Raddatz, Michael A.
    Madhur, Meena S.
    Merryman, W. David
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2019, 317 (01): : H141 - H155
  • [48] Calcific Aortic Valve Disease: a Developmental Biology Perspective
    Punashi Dutta
    Joy Lincoln
    Current Cardiology Reports, 2018, 20
  • [49] The Genetic Regulation of Aortic Valve Development and Calcific Disease
    Menon, Vinal
    Lincoln, Joy
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [50] CARTILAGINOUS METAPLASIA IN CALCIFIC AORTIC-VALVE DISEASE
    GROOM, DA
    STARKE, WR
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (06) : 809 - 812